Cipher Launches Bionect Foam

Cipher Pharmaceuticals’ prescription topical Bionect^® isnow available in the US in a lightweight foam preparation that holds its shape until application. The company says the formulation makes it easier for dermatologists to treat hard-to-reach skin areas. 

Bionect^®Foam has the same moisturizing and healing properties of Bionect^® cream and gel. It features Low Molecular Weight Hyaluronic Acid, which is naturally present in the skin and has been shown in studies to reduce signs and symptoms of inflammation and stimulate healing. As a non-steroidal, Bionect^®Foam is especially well-suited for safely dressing and managing dermal ulcers, wounds, post-operative incisions, first- and second-degree burns and other skin irritations. It also gives dermatologists and their patients a non-abrasive foam option for hard-to-reach places such as hair-bearing areas and skin folds, Cipher says.